Table 2. Clinical parameters at baseline and follow-up.
Patient | 1 | 2 | 3 | 4 | 5 | 6 | |
Baseline | TR severity | 4 | 3 | 4 | 4 | 4 | 4 |
RV ejection fraction, % | 35 | 35 | 35 | 25 | 34 | 20 | |
Reg. vol, ml/beat | 48 | 33 | 58 | 57 | 43 | 42 | |
EROA, cm2 | 0.3 | 0.2 | 0.7 | 0.3 | 0.3 | 0.4 | |
NYHA class | III | III | III | IV | III | III | |
30 days | TR severity | 3 | 1-2 | 1-2 | 2-3 | 1-2 | 2 |
RV ejection fraction, % | 35 | 35 | 35 | 35 | 45 | 29 | |
Reg. vol, ml/beat | 51 | 7 | 32 | 13 | 5 | 4 | |
EROA, cm2 | 0.32 | 0.04 | 0.2 | 0.08 | 0.03 | 0.02 | |
NYHA class | I | I | II | II | I | II | |
12 months | TR severity | 3 | 2 | 2 | 2-3 | 1 | 1 |
RV ejection fraction, % | 44 | 36 | 35 | 39 | 45 | 29 | |
Reg. vol, ml/beat | 36 | 18 | 28 | 13 | 5 | 5 | |
EROA, cm2 | 0.25 | 0.12 | 0.2 | 0.08 | 0.03 | 0.03 | |
NYHA class | I | I | II | II | I | II | |
EROA: effective regurgitant orifice area; NYHA: New York Heart Association; Reg. vol: regurgitant volume; RV: right ventricle |